Vitamin E Beats Drug Treatment for Liver Disease

Dye, Dayna
February 2010
Life Extension;Feb2010, Vol. 16 Issue 2, p16
The article discusses results of a research trial which found that vitamin E was more effective than the antidiabetic drug pioglitazone for the treatment of non-alcoholic steatohepatitis (NASH).


Related Articles

  • The Use of Complementary and Alternative Medicine for Liver Disease: Part I. Mullin, Gerard E. // Nutrition in Clinical Practice;Feb2013, Vol. 28 Issue 1, p138 

    The article reviews the evidence for and against the use of complementary and alternative medicine (CAM) modalities for liver disease in patients with chronic liver disease (CLD). It states that a majority of CLD is due to nonalcoholic fatty liver disease (NAFLD), which is associated with...

  • Editorial: Effect of Atorvastatin, Vitamin E and C on Nonalcoholic Fatty Liver Disease: Is the Combination Required? Arendt, Bianca M.; Allard, Johane P. // American Journal of Gastroenterology;Jan2011, Vol. 106 Issue 1, p78 

    Nonalcoholic fatty liver disease is associated with the metabolic syndrome. The current standard of care, healthy diet and weight loss, has limited effect. The benefits of pharmacological treatments are unclear due to the difficulty of using liver histology as the main outcome in large...

  • Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study. ALLER, R.; IZAOLA, O.; GÓMEZ, S.; TAFUR, C.; GONZÁLEZ, G.; BERROA, E.; MORA, N.; GONZÁLEZ, J. M.; DE LUIS, D. A. // European Review for Medical & Pharmacological Sciences;Aug2015, Vol. 19 Issue 16, p3118 

    OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD) is an increasingly recognized health problem. Various treatment strategies such as thiazolidinediones, metformin, lipid-lowering agents and antioxidants have been evaluated. So far, no single intervention has convincingly improved liver...

  • Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents: The TONIC Randomized Controlled Trial. Lavine, Joel E.; Schwimmer, Jeffrey B.; Van Natta, Mark L.; Molleston, Jean P.; Murray, Karen F.; Rosenthal, Philip; Abrams, Stephanie H.; Scheimann, Ann O.; Sanyal, Arun J.; Chalasani, Naga; Tonascia, James; Ünalp, Aynur; Clark, Jeanne M.; Brunt, Elizabeth M.; Kleiner, David E.; Hoofnagle, Jay H.; Robuck, Patricia R. // JAMA: Journal of the American Medical Association;4/27/2011, Vol. 305 Issue 16, p1659 

    The article discusses a randomized controlled trial concerning the role of vitamin E or metformin in the treatment of children and adolescents with nonalcoholic fatty liver disease (NAFLD). It mentions that NAFLD in children and adolescents has risen alongside the incidence of obesity in the...

  • Vitamin E Therapy in Non-Alcoholic Fatty Liver Disease. Xiangbing Shu; Li Zhang; Guang Ji // International Journal of Clinical Medicine;Jan2014, Vol. 5 Issue 3, p87 

    Non-alcoholic fatty liver disease (NAFLD) is closely related to oxidative stress. Vitamin E (VE) is an effective antioxidant, which could relieve NAFLD symptoms by improving the balance of oxidation and anti-oxidation. However, recent researches indicate that the functional mechanisms of VE are...

  • Recent Abstracts.  // Alternative Medicine Review;Dec2009, Vol. 14 Issue 4, p402 

    The article presents abstracts on alternative medicine, including the effectiveness and safety of vitamin E as treatment for muscle cramps in hemodialysis patients, effectiveness and safety of betaine as treatment for nonalcoholic fatty liver disease, and the ability of fenugreek seed to reduce...

  • Treatment of Nonalcoholic Steatohepatitis in Adults: Present and Future. Gitto, S.; Vitale, G.; Villa, E.; Andreone, P. // Gastroenterology Research & Practice;3/18/2015, Vol. 2015, p1 

    Nonalcoholic steatohepatitis has become one of the most common liver-related health problems. This condition has been linked to an unhealthy diet and weight gain, but it can also be observed in nonobese people. The standard of care is represented by the lifestyle intervention. However, because...

  • Therapies for Nonalcoholic Steatohepatitis. Mahady, Suzanne // Gastroenterology & Hepatology;Jan2013, Vol. 9 Issue 1, p40 

    An interview with the gastroenterologists and lecturer Suzanne Mahady is presented. She states that nonpharmacologic and pharmacologic treatments are the evaluated therapies for nonalcoholic steatohepatitis (NASH) patients. Mahady says that the most clinical process used for NASH patients are...

  • Antioxidant Therapy in Nonalcoholic Steatohepatitis. Al-Busafi, Said A.; Bhat, Mamatha; Wong, Philip; Ghali, Peter; Deschenes, Marc // Hepatitis Research & Treatment;2012, p1 

    Nonalcoholic steatohepatitis (NASH) affects up to 3% of the North American population. It occurs as a manifestation of the insulin-resistant state and oxidative stress is thought to be a key component of its pathophysiology. Exercise and diet, which are the mainstay of therapy, are difficult to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics